| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Chen,Jin-Cai | Chairman | 3.01% | |
| Chen,Hai-Ming | Independent Director | 0.00% | |
| Lin,Jin-Shi | Independent Director | 0.00% | |
| Li,Shen-Yi | Independent Director | 0.00% | |
| Wang,Yu-Qi | Vice Chairman | 0.15% | |
| Zhang,Wen-Ming | Director | 0.07% | |
| Chen,Shun-Ping | Director | 0.45% | |
| Ye,Li-Cheng | Director | 1.81% | |
| Xie,Ming-Jian | Director | 0.01% | |
| Chen,Guo-Hua | Director | 0.04% | |
| Zhang,Zhao-Shun | Independent Director | 0.00% |
下載完整報告查看完整數據
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 3,575,803 | 17,457,713 | 15,836,498 |
| Operating cost | 2,977,395 | 13,415,743 | 12,367,333 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 598,408 | 4,041,970 | 3,469,165 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 598,408 | 4,041,970 | 3,469,165 |
| Operating expenses | 814,974 | 3,279,938 | 3,524,827 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | -216,566 | 762,032 | -55,662 |
| Non-operating income and expenses | 155,672 | -429,238 | -623,370 |
| Net profit (loss) before tax | -60,894 | 332,794 | -679,032 |
| Income tax expense (benefits) | 2,440 | -7,017 | -121,054 |
| Net profit (loss) of ongoing business for the current period | -63,334 | 339,811 | -557,978 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | -63,334 | 339,811 | -557,978 |
| Other comprehensive profit (loss), net | -1,371,443 | 3,441,119 | 1,762,438 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | -1,434,777 | 3,780,930 | 1,204,460 |
| Net profit (loss) attributable to owners of parent company | 15,628 | 768,133 | -79,657 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | -78,962 | -428,322 | -478,321 |
| Comprehensive profit (loss) attributable to owners of parent company | -1,371,634 | 4,159,963 | 1,683,412 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | -63,143 | -379,033 | -478,952 |
| Basic earnings per share (yuan) | 0 | 1 | 0 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | 1,097,488 | 4,900,014 | 4,269,533 |
| Net cash inflows (outflows) from investing activities | -40,467 | -1,055,499 | -2,753,174 |
| Net cash inflow (outflow) from financing activities | -938,666 | -8,938,763 | -1,676,146 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 8,423 | 187,844 | 105,784 |
| Increase (decrease) in cash and cash equivalents in the current period | 126,778 | -4,906,404 | -54,003 |
| Beginning balance of cash and cash equivalents | 5,419,305 | 10,325,709 | 10,379,712 |
| Ending balance of cash and cash equivalents | 5,546,083 | 5,419,305 | 10,325,709 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 12,178,073 | 12,455,432 | 17,163,327 |
| Non-current asset | 49,770,652 | 51,803,325 | 52,004,708 |
| Total asset | 61,948,725 | 64,258,757 | 69,168,035 |
| Current liability | 4,839,614 | 7,603,238 | 12,723,634 |
| Non-current liability | 19,828,177 | 17,517,468 | 21,095,070 |
| Total liability | 24,667,791 | 25,120,706 | 33,818,704 |
| share capital | 4,239,404 | 4,239,404 | 4,239,404 |
| Equity - secruity token | - | - | - |
| capital reserve | 9,970,858 | 9,970,132 | 9,967,188 |
| retained earning | 17,595,944 | 17,997,492 | 17,212,996 |
| Other equity | 4,517,050 | 5,911,076 | 2,535,609 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 36,323,256 | 38,118,104 | 33,955,197 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 957,678 | 1,019,947 | 1,394,134 |
| Total Equity | 37,280,934 | 39,138,051 | 35,349,331 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 85 | 89 | 80 |
| 標案名稱 | 機關名稱 | 決標日期 | 決標金額 | 是否得標 |
|---|---|---|---|---|
| 增強耐濕型三五族化合物半導體積體電路製作一套 | 國立中央大學 | 109/04/08 | 600000.0 | 是 |
| 三五族化合物半導體積體電路製作1套 | 國立中央大學 | 106/09/22 | 1260000.0 | 是 |
| 砷化鎵微波積體電路組晶圓代工製造一式 | 國立交通大學 | 105/08/02 | 1260000.0 | 是 |
| 砷化鎵晶圓一式 | 中央研究院 | 105/01/26 | 2205000.0 | 是 |
| 氮化鎵微波積體元件組等1項 | 國防部軍備局中山科學研究院 | 102/08/01 | 4140360.0 | 是 |
Others
2008, 2009
Pay off debt
2013
Pay salary etc.
2011
Compensation for damage
2018
Civil lawsuit for forgery
2007
Confirmation of the existence of employment relationship, etc
2011
Others
2009, 2010, 2011, 2013
Compensation for damage
2019
Invalidating Judgment (Note)
2014
Petition filed for public summons
2012, 2013
Profit-seeking Enterprise Income Tax
2016, 2017
Petition for confidentiality preservation order
2018
Confirmation of the existence of employment relationship, etc
2011, 2024
| 日期 | 違反法規法條 | 罰鍰金額 |
|---|---|---|
| 2024/03/08 | Paragraph 1, Article 6 of the Occupational Safety and Health Act; Paragraph 1, Article 6 of the Occupational Safety and Health Act | |
| 2023/03/03 | Paragraph 1, Article 24 of the Labor Standards Act | 50,000 |
| 2019/09/10 | Paragraph 1, Article 6 of the Occupational Safety and Health Act | |
| 2019/08/12 | Paragraph 1, Article 6 of the Occupational Safety and Health Act | |
| 2018/01/26 | Paragraph 1, Article 6 of the Occupational Safety and Health Act | |
| 2016/06/10 | Paragraph 2, Article 22 of the Labor Standards Act |
